Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 11 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Cyclophosphamide 5 Radiotherapy 3 Automobiles 3 fludarabine 2 Vincristine 2 Temozolomide 2 Eflornithine 2 Cisplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 belzutifan 1 Zoledronic Acid 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Maintenance Chemotherapy 1 Lomustine 1 Infusions, Intravenous 1 Induction Chemotherapy 1 HhAntag691 1 Gemcitabine 1 Exercise 1 Etoposide 1 Drug Therapy 1 Diploidy 1 Craniospinal Irradiation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡